<DOC>
	<DOC>NCT01419678</DOC>
	<brief_summary>This is a single center, observational study of posaconazole PK sampling in lung transplant recipients. The patients enrolled will have up to 6 (3ml) pk samples (a total of 18 ml) and one 10ml blood sample for a total collection of 28ml of blood obtained over the entire study. In addition, the investigators will collect medical record information and any excess BAL samples available during the study (tests done as part of the patient's clinical care and the samples would have been discarded once diagnosis was made).</brief_summary>
	<brief_title>Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients</brief_title>
	<detailed_description>PK blood samples will be obtained around a clinical dosing of posaconazole</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>18 years of age and older receiving posaconazole post transplant as part of their care received a lung transplant must meet inclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>posaconazole</keyword>
	<keyword>PK blood sampling</keyword>
</DOC>